{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:59:15Z","timestamp":1768874355183,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jtho.2017.10.016","type":"journal-article","created":{"date-parts":[[2017,11,5]],"date-time":"2017-11-05T00:02:38Z","timestamp":1509840158000},"page":"258-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma"],"prefix":"10.1016","volume":"13","author":[{"given":"Thomas G.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Schelch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuen Y.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marissa","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kadir H.","family":"Sarun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela B.","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Linton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Klebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian C.","family":"McCaughan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruby C.Y.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Pirker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Lasham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico","family":"van Zandwijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glen","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2017.10.016_bib1","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2017.10.016_bib2","first-page":"E254","article-title":"Guidelines for the diagnosis and treatment of malignant pleural mesothelioma","volume":"5","author":"van Zandwijk","year":"2013","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jtho.2017.10.016_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.critrevonc.2012.03.001","article-title":"The ticking time-bomb of asbestos: its insidious role in the development of malignant mesothelioma","volume":"84","author":"Linton","year":"2012","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"10.1016\/j.jtho.2017.10.016_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.aogh.2016.01.019","article-title":"The global health dimensions of asbestos and asbestos-related diseases","volume":"82","author":"Takahashi","year":"2016","journal-title":"Ann Glob Health"},{"key":"10.1016\/j.jtho.2017.10.016_bib5","doi-asserted-by":"crossref","first-page":"e10612","DOI":"10.1371\/journal.pone.0010612","article-title":"Second generation sequencing of the mesothelioma tumor genome","volume":"5","author":"Bueno","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jtho.2017.10.016_bib6","first-page":"5547","article-title":"p16 alterations and deletion mapping of 9p21\u2013p22 in malignant mesothelioma","volume":"54","author":"Cheng","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2017.10.016_bib7","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/modpathol.2008.45","article-title":"Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas","volume":"21","author":"Chiosea","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtho.2017.10.016_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc3459","article-title":"BAP1 and cancer","volume":"13","author":"Carbone","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jtho.2017.10.016_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.humpath.2016.04.015","article-title":"Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization array","volume":"55","author":"Chirac","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jtho.2017.10.016_bib10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/onc.2015.125","article-title":"Role of merlin\/NF2 inactivation in tumor biology","volume":"35","author":"Petrilli","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.jtho.2017.10.016_bib11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1440-1827.2011.02666.x","article-title":"Inactivation of merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation","volume":"61","author":"Yoshitaka","year":"2011","journal-title":"Pathol Int"},{"key":"10.1016\/j.jtho.2017.10.016_bib12","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/(SICI)1097-4652(199908)180:2<150::AID-JCP2>3.0.CO;2-H","article-title":"Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma","volume":"180","author":"Murthy","year":"1999","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jtho.2017.10.016_bib13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.12691\/ajmbr-1-4-8","article-title":"Comparative genomic hybridization studies on mesothelioma show a parallel fate of 1p21-1p22 and 9p21 bands and a chromosomally stable sub-group","volume":"1","author":"Melaiu","year":"2013","journal-title":"Am J Med Biol Res"},{"key":"10.1016\/j.jtho.2017.10.016_bib14","doi-asserted-by":"crossref","first-page":"22809","DOI":"10.1074\/jbc.M110.100354","article-title":"Pro-tumorigenic effects of miR-31 loss in mesothelioma","volume":"285","author":"Ivanov","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtho.2017.10.016_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrg3965","article-title":"Towards a molecular understanding of microRNA-mediated gene silencing","volume":"16","author":"Jonas","year":"2015","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jtho.2017.10.016_bib16","first-page":"1","article-title":"Exploring mechanisms of microRNA downregulation in cancer","volume":"5","author":"Williams","year":"2016","journal-title":"MicroRNA"},{"key":"10.1016\/j.jtho.2017.10.016_bib17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ebiom.2016.09.017","article-title":"MicroRNA therapeutics in cancer\u2014an emerging concept","volume":"12","author":"Shah","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jtho.2017.10.016_bib18","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2217\/epi-2016-0035","article-title":"Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer","volume":"8","author":"Reid","year":"2016","journal-title":"Epigenomics"},{"key":"10.1016\/j.jtho.2017.10.016_bib19","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1158\/0008-5472.CAN-10-0622","article-title":"Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis","volume":"70","author":"Francesc","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2017.10.016_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1741-7015-6-14","article-title":"miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells","volume":"6","author":"Joachim","year":"2008","journal-title":"BMC Med"},{"key":"10.1016\/j.jtho.2017.10.016_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/PAT.0b013e328342016c","article-title":"Validation of tissue microarray technology in malignant pleural mesothelioma","volume":"43","author":"Kao","year":"2011","journal-title":"Pathology"},{"key":"10.1016\/j.jtho.2017.10.016_bib22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/bjc.2013.731","article-title":"An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma","volume":"110","author":"Linton","year":"2014","journal-title":"British J Cancer"},{"key":"10.1016\/j.jtho.2017.10.016_bib23","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/bioinformatics\/18.11.1427","article-title":"MethPrimer: designing primers for methylation PCRs","volume":"18","author":"Long-Cheng","year":"2002","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jtho.2017.10.016_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.jtho.2017.10.016_bib25","doi-asserted-by":"crossref","first-page":"e90374","DOI":"10.1371\/journal.pone.0090374","article-title":"Cilengitide inhibits attachment and invasion of malignant pleural mesothelioma cells through antagonism of integrins \u03b1v\u03b23 and \u03b1v\u03b25","volume":"9","author":"Cheng","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jtho.2017.10.016_bib26","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/annonc\/mdt412","article-title":"Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma","volume":"24","author":"Reid","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2017.10.016_bib27","doi-asserted-by":"crossref","first-page":"23480","DOI":"10.18632\/oncotarget.4346","article-title":"miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma","volume":"6","author":"Williams","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtho.2017.10.016_bib28","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1158\/1078-0432.CCR-10-3040","article-title":"Epigenetic silencing of microRNA-34b\/c plays an important role in the pathogenesis of malignant pleural mesothelioma","volume":"17","author":"Kubo","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2017.10.016_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2141.2007.06750.x","article-title":"Chromosome 1p21 deletion is a novel prognostic marker in patients with multiple myeloma","volume":"139","author":"Chang","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtho.2017.10.016_bib30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.leukres.2008.06.027","article-title":"Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia","volume":"33","author":"Chang","year":"2009","journal-title":"Leukemia Res"},{"key":"10.1016\/j.jtho.2017.10.016_bib31","doi-asserted-by":"crossref","first-page":"e109734","DOI":"10.1371\/journal.pone.0109734","article-title":"MicroRNA-137 upregulation increases bladder cancer cell proliferation and invasion by targeting PAQR3","volume":"9","author":"Xiu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jtho.2017.10.016_bib32","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/jid.2012.357","article-title":"miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes","volume":"133","author":"Luo","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jtho.2017.10.016_bib33","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3892\/or.2012.1958","volume":"28","author":"Sun","year":"2012","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jtho.2017.10.016_bib34","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/PAT.0000000000000250","article-title":"Loss of expression of BAP1 predicts longer survival in mesothelioma","volume":"47","author":"Farzin","year":"2015","journal-title":"Pathology"},{"key":"10.1016\/j.jtho.2017.10.016_bib35","doi-asserted-by":"crossref","first-page":"e0130124","DOI":"10.1371\/journal.pone.0130124","article-title":"MicroRNA-137 contributes to dampened tumorigenesis in human gastric cancer by targeting AKT2","volume":"10","author":"Wu","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jtho.2017.10.016_bib36","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1016\/j.febslet.2014.07.012","article-title":"miR-137 effects on gastric carcinogenesis are mediated by targeting Cox-2-activated PI3K\/AKT signaling pathway","volume":"588","author":"Cheng","year":"2014","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jtho.2017.10.016_bib37","first-page":"3696","article-title":"Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): in\u00a0vitro antiproliferative effects of a COX-2 inhibitor","volume":"60","author":"Marrogi","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2017.10.016_bib38","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1158\/1078-0432.CCR-14-1437","article-title":"miR-137 and miR-197 induce apoptosis and suppress tumorigenicity by targeting MCL-1 in multiple myeloma","volume":"21","author":"Yang","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2017.10.016_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/BJ20121323","article-title":"YB-1: oncoprotein, prognostic marker and therapeutic target?","volume":"449","author":"Lasham","year":"2013","journal-title":"Biochem J"},{"key":"10.1016\/j.jtho.2017.10.016_bib40","first-page":"1","article-title":"MicroRNA-137 chemosensitizes colon cancer cells to the chemotherapeutic drug oxaliplatin (OXA) by targeting YBX1","author":"Guo","year":"2016","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.jtho.2017.10.016_bib41","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/abbs\/gms099","article-title":"miR-137 restoration sensitizes multidrug-resistant MCF-7\/ADM cells to anticancer agents by targeting YB-1","volume":"45","author":"Zhu","year":"2013","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.jtho.2017.10.016_bib42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000356874","article-title":"Clinical significance of epithelial-mesenchymal transition-associated markers in malignant pleural mesothelioma","volume":"86","author":"Iwanami","year":"2014","journal-title":"Oncology"},{"key":"10.1016\/j.jtho.2017.10.016_bib43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/mt.2014.197","article-title":"miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1","volume":"23","author":"Xu","year":"2015","journal-title":"Mol Ther"},{"key":"10.1016\/j.jtho.2017.10.016_bib44","doi-asserted-by":"crossref","first-page":"E142","DOI":"10.1111\/j.1464-410X.2010.09810.x","article-title":"Twist1 and Y-box-binding protein-1 promote malignant potential in\u00a0bladder cancer cells","volume":"108","author":"Shiota","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.jtho.2017.10.016_bib45","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ccr.2007.03.012","article-title":"Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics","volume":"11","author":"MacDiarmid","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtho.2017.10.016_bib46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/jnci\/djr512","article-title":"YB-1, the E2F pathway, and regulation of tumor cell growth","volume":"104","author":"Lasham","year":"2012","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jtho.2017.10.016_bib47","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nbt.1547","article-title":"Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug","volume":"27","author":"MacDiarmid","year":"2009","journal-title":"Nat Biotech"},{"key":"10.1016\/j.jtho.2017.10.016_bib48","doi-asserted-by":"crossref","first-page":"e12661","DOI":"10.1371\/journal.pone.0012661","article-title":"Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability","volume":"5","author":"Law","year":"2010","journal-title":"PLoS One"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086417328605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086417328605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T14:39:12Z","timestamp":1549031952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086417328605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1556086417328605"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2017.10.016","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2017.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}